Principal Financial Group Inc. increased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Rating) by 22.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 90,735 shares of the medical instruments supplier’s stock after purchasing an additional 16,855 shares during the quarter. Principal Financial Group Inc. owned 1.73% of Mesa Laboratories worth $29,601,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. US Bancorp DE increased its position in shares of Mesa Laboratories by 7.7% during the 3rd quarter. US Bancorp DE now owns 11,526 shares of the medical instruments supplier’s stock worth $3,485,000 after purchasing an additional 824 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Mesa Laboratories by 14.3% during the 3rd quarter. Renaissance Technologies LLC now owns 27,100 shares of the medical instruments supplier’s stock worth $8,194,000 after purchasing an additional 3,400 shares during the last quarter. M&T Bank Corp boosted its holdings in Mesa Laboratories by 57.5% during the 4th quarter. M&T Bank Corp now owns 1,213 shares of the medical instruments supplier’s stock valued at $399,000 after acquiring an additional 443 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Mesa Laboratories by 233.5% during the 3rd quarter. Goldman Sachs Group Inc. now owns 19,457 shares of the medical instruments supplier’s stock valued at $5,883,000 after acquiring an additional 13,622 shares during the period. Finally, California State Teachers Retirement System boosted its holdings in Mesa Laboratories by 2.0% during the 3rd quarter. California State Teachers Retirement System now owns 6,899 shares of the medical instruments supplier’s stock valued at $2,086,000 after acquiring an additional 137 shares during the period. 91.90% of the stock is owned by hedge funds and other institutional investors.
Shares of MLAB opened at $217.98 on Friday. The stock has a 50-day simple moving average of $243.93 and a 200-day simple moving average of $279.34. The company has a debt-to-equity ratio of 0.58, a quick ratio of 2.08 and a current ratio of 2.59. The stock has a market capitalization of $1.14 billion, a PE ratio of 152.43 and a beta of 0.54. Mesa Laboratories, Inc. has a 1 year low of $210.11 and a 1 year high of $333.42.
In other news, CFO John Sakys sold 930 shares of the firm’s stock in a transaction dated Wednesday, March 23rd. The stock was sold at an average price of $251.29, for a total transaction of $233,699.70. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John James Sullivan sold 5,192 shares of the firm’s stock in a transaction dated Tuesday, February 15th. The stock was sold at an average price of $259.42, for a total value of $1,346,908.64. The disclosure for this sale can be found here. Insiders sold a total of 6,194 shares of company stock valued at $1,598,640 in the last quarter. Company insiders own 5.10% of the company’s stock.
MLAB has been the subject of a number of research analyst reports. StockNews.com initiated coverage on Mesa Laboratories in a report on Thursday, March 31st. They set a “hold” rating for the company. Zacks Investment Research cut Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, April 6th.
Mesa Laboratories Company Profile (Get Rating)
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
- Get a free copy of the StockNews.com research report on Mesa Laboratories (MLAB)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.